Alar Pharmaceuticals Inc. (6785.TWO)

TWD 138.5

(-1.07%)

Long Term Debt Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual long term debt in 2023 was 138 Thousand TWD , down -90.19% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly long term debt in 2024 Q2 was 104 Thousand TWD , down 0.0% from previous quarter.
  • Alar Pharmaceuticals Inc. reported annual long term debt of 1.4 Million TWD in 2022, up 417.28% from previous year.
  • Alar Pharmaceuticals Inc. reported annual long term debt of 272 Thousand TWD in 2021, down -55.56% from previous year.
  • Alar Pharmaceuticals Inc. reported quarterly long term debt of 104 Thousand TWD for 2024 Q2, down 0.0% from previous quarter.
  • Alar Pharmaceuticals Inc. reported quarterly long term debt of 421 Thousand TWD for 2023 Q3, down -44.09% from previous quarter.

Annual Long Term Debt Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Long Term Debt of Alar Pharmaceuticals Inc. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 138 Thousand TWD -90.19%
2022 1.4 Million TWD 417.28%
2021 272 Thousand TWD -55.56%
2020 612 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer Long Term Debt Comparison of Alar Pharmaceuticals Inc.

Name Long Term Debt Long Term Debt Difference
Allied Biotech Corporation 72.02 Million TWD 99.808%
GeneFerm Biotechnology Co., Ltd. 76.14 Million TWD 99.819%
Easywell Biomedicals, Inc. 330.44 Million TWD 99.958%
TTY Biopharm Company Limited 403.04 Million TWD 99.966%
Synmosa Biopharma Corporation 1.45 Billion TWD 99.991%
Orient EuroPharma Co., Ltd. 2.2 Billion TWD 99.994%
Center Laboratories, Inc. 4.42 Billion TWD 99.997%
Tien Liang BioTech Co., Ltd. 377 Thousand TWD 63.395%
Orient Pharma Co., Ltd. 323.73 Million TWD 99.957%
InnoPharmax Inc. 5.38 Million TWD 97.438%
Johnson Chemical Pharmaceutical Works Co., Ltd. 100.83 Million TWD 99.863%
Excelsior Biopharma Inc. 300.25 Million TWD 99.954%
DV Biomed Co., Ltd. 315.74 Million TWD 99.956%
Foresee Pharmaceuticals Co., Ltd. 13.11 Million TWD 98.948%
Handa Pharmaceuticals, Inc. 7.67 Million TWD 98.201%
UniPharma Co., Ltd. - TWD -Infinity%
Anxo Pharmaceutical Co., Ltd. 499.69 Million TWD 99.972%
Winston Medical Supply Co., Ltd. 56.05 Million TWD 99.754%
Mercury Biopharmaceutical Corporation 41.66 Million TWD 99.669%
Bioray Biotech Co., Ltd 65.65 Million TWD 99.79%
TSH Biopharm Corporation Limited - TWD -Infinity%